News & Perspective

Oct 27, 2003

Oct 27, 2003

FDA outlines how to gauge risk that animal drugs will spawn superbugs

Editor's note: This story was updated from its original form to include additional details about the FDA guidelines and comments from a pharmaceutical industry representative.

(CIDRAP News) – The Food and Drug Administration (FDA) has released a guide to help the drug industry assess the risk that antimicrobial drugs intended for use in food animals will spawn resistant bacteria that could ultimately harm human health.